To investigate whether the SUMO pathway could be responsible for the intracellular retention of PVR and Nectin2 in MM cells, we took advantage of the use of Ginkgolic Acid (GA), an inhibitor of SAE1/UBA2, the E1 enzyme responsible for SUMO modification33. This evidence concerns the gene NECTIN2 and Miyoshi myopathy.